跳至主要内容
临床试验/ISRCTN93952605
ISRCTN93952605已完成不适用

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, international normalised ratio (INR) control, and outcome of Treatment with warfarin

Bayer Plc (UK)0 个研究点目标入组 200 人开始时间: 2008年12月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Atrial fibrillation patients newly referred for, and accepting of, anticoagulant therapy
  • 2. Aged 18 years or older, either sex

排除标准

  • 1. Aged less than 18 years old
  • 2. Have any contraindication to warfarin or have previously received warfarin
  • 3. Have valvular heart disease
  • 4. Are cognitively impaired
  • 5. Have any disease likely to cause their death within 12 months

研究者

发起方
Bayer Plc (UK)

相似试验

Educational intervention for atrial fibrillatio | 临床试验